Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Biological therapy-related hepatosplenic T-cell lymphoma

    • 11 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Shah ED, et al. Systematic review: hepatosplenic T-cell lymphoma on biologic therapy for inflammatory bowel disease, including data from the Food and Drug Administration Adverse Event Reporting System. Alimentary Pharmacology and Therapeutics : 28 Jan 2020. Available from: URL: http://doi.org/10.1111/apt.15637

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Biological therapy-related hepatosplenic T-cell lymphoma. Reactions Weekly 1790, 6 (2020). https://doi.org/10.1007/s40278-020-74625-z

    Download citation